Eupraxia pharmaceuticals announces voting results from annual general and special meeting of shareholders

Victoria, bc , june 6, 2024 /prnewswire/ - eupraxia pharmaceuticals inc. ("eupraxia" or the "company") (tsx: eprx) (nasdaq: eprx), a clinical-stage biotechnology company leveraging its proprietary diffusphere™ technology to optimize drug delivery for applications with significant unmet need, is pleased to announce the results from its annual general and special meeting of shareholders (the "meeting") held on june 6, 2024. pursuant to a resolution passed by ballot vote, all of the six nominees proposed by management for election to the company's board of directors (the "board") at the meeting and listed in the company's management information circular dated may 1, 2024, were elected.
GM Ratings Summary
GM Quant Ranking